Over the past three decades, rates of pulmonary arterial hypertension (PAH) have increased in wealthy parts of the world,…
Articles by Marisa Horak, MS
People newly diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH) who have lower exercise capacity and poorer breathing efficiency during…
The U.S. Food and Drug Administration (FDA) has approved an update to the prescribing information for Winrevair (sotatercept-csrk), an…
Measurements that look at the interplay between the pulmonary arteries and the heart may help predict the likelihood of survival…
A noninvasive measure of heart and blood vessel function called the TAPSE/sPAP ratio can help doctors objectively assess the severity…
A measurement taken by heart MRI was linked to several invasive measures used to assess pulmonary hypertension (PH), a…
Adults with pulmonary arterial hypertension (PAH) taking Remodulin (treprostinil) or Veletri (epoprostenol) safely switched to Uptravi…
A measure derived from heart and lung imaging data can predict the long-term risk of death for people with newly…
A novel score calculated based on markers of liver and heart health may help to predict the risk of future…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to IKT-001, an experimental formulation of imatinib that…
People with pulmonary arterial hypertension (PAH) have less diversity among the viruses that infect bacteria in their digestive tracts,…
Respiratory rehabilitation is safe and can help improve exercise capacity in people with chronic obstructive pulmonary disease (COPD) with…